NVO - Novo Nordisk A/S

NYSE - NYSE Delayed price. Currency in USD
64.96
+2.17 (+3.46%)
At close: 4:00PM EDT

65.60 +0.64 (0.99%)
Pre-market: 9:22AM EDT

Stock chart is not supported by your current browser
Previous close62.79
Open64.17
Bid66.02 x 1000
Ask65.84 x 800
Day's range64.13 - 65.56
52-week range46.92 - 66.02
Volume1,608,853
Avg. volume2,333,235
Market cap151.483B
Beta (5Y monthly)0.44
PE ratio (TTM)26.39
EPS (TTM)2.46
Earnings dateN/A
Forward dividend & yield1.57 (2.41%)
Ex-dividend date27 Mar 2020
1y target est69.45
  • Pharma Stock Roundup: Q1 Earnings of BMY, NVO, Coronavirus Update From PFE, RHHBY
    Zacks

    Pharma Stock Roundup: Q1 Earnings of BMY, NVO, Coronavirus Update From PFE, RHHBY

    Novo Nordisk (NVO) and Bristol-Myers (BMY) announce Q1 results. Pfizer (PFE), Roche (RHHBY) and Lilly (LLY) provide update on their coronavirus-related research efforts.

  • Novo Nordisk A/S (CPH:NOVO B) Just Beat Earnings: Here's What Analysts Think Will Happen Next
    Simply Wall St.

    Novo Nordisk A/S (CPH:NOVO B) Just Beat Earnings: Here's What Analysts Think Will Happen Next

    A week ago, Novo Nordisk A/S (CPH:NOVO B) came out with a strong set of quarterly numbers that could potentially lead...

  • Novo Nordisk's (NVO) Q1 Earnings and Sales Beat Estimates
    Zacks

    Novo Nordisk's (NVO) Q1 Earnings and Sales Beat Estimates

    Novo Nordisk (NVO) beats on Q1 sales and earnings, and maintains outlook amid the coronavirus pandemic.

  • Why quality and momentum matters for Novo Nordisk A/s (CPH:NOVO B)
    Stockopedia

    Why quality and momentum matters for Novo Nordisk A/s (CPH:NOVO B)

    Quality and momentum are highly prized among investors looking for reliable investment ideas. That's because good quality stocks tend to be resilient, cash-gen8230;

  • Novo Nordisk A/S (NVO) Q1 2020 Earnings Call Transcript
    Motley Fool

    Novo Nordisk A/S (NVO) Q1 2020 Earnings Call Transcript

    Image source: The Motley Fool. Novo Nordisk A/S (NYSE: NVO)Q1 2020 Earnings CallMay 6, 2020, 7:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorHello and welcome to the Q1 2020 Novo Nordisk AS Earnings Conference Call.

  • Reuters - UK Focus

    GLOBAL MARKETS-World shares mixed amid hopes for business pickup, oil slips

    Oil prices slid and world equity markets seesawed on Wednesday as investor hopes for a pickup in business activity were dashed by downbeat economic data and a rise in U.S. crude stockpiles to three-year highs that highlighted low fuel demand. The safe-haven Japanese yen and dollar rose on data showing U.S. private payrolls tumbled by a record 20.2 million workers in April, German industrial orders fell at a record pace in March, and British construction activity fell to an all-time low last month. The dollar index rose 0.299%, with the euro down 0.34% to $1.0801.

  • Reuters - UK Focus

    GLOBAL MARKETS-World shares mixed amid hopes for business pickup; oil slides

    Oil prices slid and world equity markets seesawed on Wednesday as investor hopes for a pickup in business activity were weighed against downbeat economic data and low fuel demand highlighted by a rise in U.S. crude stockpiles to three-year highs. The safe-haven Japanese yen and dollar rose on data showing U.S. private payrolls tumbled to a record 20.2 million in April, German industrial orders fell at a record pace in March and British construction activity fell to an all-time low last month. The Japanese yen strengthened 0.54% versus the greenback at 106.05 per dollar.

  • Reuters - UK Focus

    GLOBAL MARKETS-World shares mixed amid hopes for business pickup, weak data; oil slides

    World equity markets were mixed on Wednesday, with U.S. indexes seesawing amid hopes for a pickup in business activity and as oil prices slumped with demand low after a rise in U.S. crude stockpiles last week to three-year highs. The safe-haven Japanese yen and dollar rose after economic data showed U.S. private payrolls tumbled last month to a record 20.2 million, German industrial orders fell at a record pace in March and UK construction activity crashed to an all-time low in April. The Japanese yen strengthened 0.49% versus the greenback at 106.10 per dollar.

  • Reuters - UK Focus

    GLOBAL MARKETS-World shares subdued amid weak data; oil resumes gains

    Global shares struggled on Wednesday as weak economic data, doubts about the easing of coronavirus lockdowns and simmering U.S.-China tensions cast a pall over markets. Oil prices extended their run of gains, supported by expectations that demand will recover and by a record supply cut from OPEC and other producers.

  • Novo Nordisk's drug sales boosted by virus-related stockpiling
    Reuters

    Novo Nordisk's drug sales boosted by virus-related stockpiling

    The world's top maker of diabetes drugs Novo Nordisk <NOVOb.CO> beat profit and sales forecasts in the first quarter and kept its full-year outlook as diabetics stocking up during the coronavirus pandemic led to a surge in demand for its medicines. Novo Nordisk joined U.S. rival Eli Lilly <LLY.N> and other drugmakers in keeping or even raising full-year forecasts as lockdowns to combat the spread of the virus lead to stockpiling of drugs. "COVID-19 related stocking at patient levels significantly impacted our results, however, we are satisfied with the underlying performance," Chief Executive Lars Fruergaard Jorgensen told journalists on Wednesday.

  • SNY vs. NVO: Which Stock Is the Better Value Option?
    Zacks

    SNY vs. NVO: Which Stock Is the Better Value Option?

    SNY vs. NVO: Which Stock Is the Better Value Option?

  • The Zacks Analyst Blog Highlights: Visa, Novo Nordisk, American Tower, Caterpillar and 3M
    Zacks

    The Zacks Analyst Blog Highlights: Visa, Novo Nordisk, American Tower, Caterpillar and 3M

    The Zacks Analyst Blog Highlights: Visa, Novo Nordisk, American Tower, Caterpillar and 3M

  • Tracking Q2 and Full-Year 2020 Earnings Estimates
    Zacks

    Tracking Q2 and Full-Year 2020 Earnings Estimates

    Tracking Q2 and Full-Year 2020 Earnings Estimates

  • Reuters - UK Focus

    LIVE MARKETS-Will telcos be left behind post Covid, QE?

    * HSBC, UBS, Santander: mixed Q1 results Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Thyagaraju Adinarayan (thyagaraju.adinarayan@thomsonreuters.com), Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Stefano Rebaudo (stefano.rebaudo@thomsonreuters.com) in Milan.

  • Reuters - UK Focus

    LIVE MARKETS-Broadcasters hit harder by advertising decline, all focus on Q3

    * HSBC, UBS, Santander: mixed Q1 results Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Thyagaraju Adinarayan (thyagaraju.adinarayan@thomsonreuters.com), Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Stefano Rebaudo (stefano.rebaudo@thomsonreuters.com) in Milan.

  • Reuters - UK Focus

    LIVE MARKETS-French mom-and-pop investors in pandemic buying frenzy

    * HSBC, UBS, Santander: mixed Q1 results Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Thyagaraju Adinarayan (thyagaraju.adinarayan@thomsonreuters.com), Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Stefano Rebaudo (stefano.rebaudo@thomsonreuters.com) in Milan. There's been quite a lot written about pasta and flour stockpiling but piling up stocks during the worst economic and financial crisis in living memory is an interesting one!

  • Reuters - UK Focus

    LIVE MARKETS-GRANOLAS heavier than the FAAAM'ous five

    * HSBC, UBS, Santander: mixed Q1 results Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Thyagaraju Adinarayan (thyagaraju.adinarayan@thomsonreuters.com), Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Stefano Rebaudo (stefano.rebaudo@thomsonreuters.com) in Milan.

  • Novo Nordisk (CPH:NOVO B) Could Easily Take On More Debt
    Simply Wall St.

    Novo Nordisk (CPH:NOVO B) Could Easily Take On More Debt

    Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

  • Reuters - UK Focus

    LIVE MARKETS-Where is the end of the tunnel?

    You can share your thoughts with Thyagaraju Adinarayan (thyagaraju.adinarayan@thomsonreuters.com), Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Stefano Rebaudo (stefano.rebaudo@thomsonreuters.com) in Milan. HOW CORONAVIRUS COULD HURT GLOBAL TRADE LONG-TERM?

  • The Zacks Analyst Blog Highlights: Alibaba, Pfizer, S&P Global, Novo Nordisk and Duke Energy
    Zacks

    The Zacks Analyst Blog Highlights: Alibaba, Pfizer, S&P Global, Novo Nordisk and Duke Energy

    The Zacks Analyst Blog Highlights: Alibaba, Pfizer, S&P Global, Novo Nordisk and Duke Energy

  • Reuters - UK Focus

    LIVE MARKETS-U.S. stocks to outperform, but credit... Even better!

    You can share your thoughts with Thyagaraju Adinarayan (thyagaraju.adinarayan@thomsonreuters.com), Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Stefano Rebaudo (stefano.rebaudo@thomsonreuters.com) in Milan. HOW CORONAVIRUS COULD HURT GLOBAL TRADE LONG-TERM?

  • Reuters - UK Focus

    LIVE MARKETS-The hottest stocks in the world!

    You can share your thoughts with Thyagaraju Adinarayan (thyagaraju.adinarayan@thomsonreuters.com), Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Stefano Rebaudo (stefano.rebaudo@thomsonreuters.com) in Milan. - Tesla's future is pretty uncertain as its outlook mostly depends on Chinese production.

  • Novo Nordisk's Rybelsus Gets EU Nod for Type II Diabetes
    Zacks

    Novo Nordisk's Rybelsus Gets EU Nod for Type II Diabetes

    Novo Nordisk (NVO) gains the EU approval for Rybelsus to address adult patients with insufficiently-controlled type II diabetes for improving glycemic control as an adjunct to diet and exercise.

  • NVS vs. NVO: Which Stock Should Value Investors Buy Now?
    Zacks

    NVS vs. NVO: Which Stock Should Value Investors Buy Now?

    NVS vs. NVO: Which Stock Is the Better Value Option?

  • The Zacks Analyst Blog Highlights: Alphabet, Procter & Gamble, Philip Morris, Novo Nordisk and Tesla
    Zacks

    The Zacks Analyst Blog Highlights: Alphabet, Procter & Gamble, Philip Morris, Novo Nordisk and Tesla

    The Zacks Analyst Blog Highlights: Alphabet, Procter & Gamble, Philip Morris, Novo Nordisk and Tesla

By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more